id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_ellbtzc6yvc6jpygzzkvdligbe	JJ Gagne	ND4 IMPACT OF TOPIRAMATE FOR MIGRAINE PROPHYLAXIS ON WORKPLACE PRODUCTIVITY: RESULTS FROM TWO U.S. RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIALS	2006	1	.pdf	application/pdf	388	30	67	ND4 IMPACT OF TOPIRAMATE FOR MIGRAINE PROPHYLAXIS ON WORKPLACE PRODUCTIVITY: RESULTS FROM TWO U.S. RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIALS IMPACT OF TOPIRAMATE FOR MIGRAINE PROPHYLAXIS ON WORKPLACE PRODUCTIVITY: RESULTS FROM TWO U.S. RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, OBJECTIVE: To compare the impact of topiramate 100 mg/day versus placebo on workplace productivity among individuals with migraine, using data from two six-month randomized, Total lost productivity was the sum of A The mean monthly (28-day) rate of lost productivity per RESULTS: A total of 449 subjects were enrolled in the trials (226 lost productivity at baseline (162 topiramate, 163 placebo). At baseline, the mean rates of total lost productivity were 10.4 hours/28 days for topiramate 100 mg/d and 10.1 hours/28 days for placebo (not significant). productivity hours/28 days for topiramate 100 mg/d versus Our findings suggest that topiramate 100 mg/day may be associated with improvements in productivity among individuals with migraine.	./cache/work_ellbtzc6yvc6jpygzzkvdligbe.pdf	./txt/work_ellbtzc6yvc6jpygzzkvdligbe.txt